Free Trial

Marinus Pharmaceuticals (MRNS) Earnings Date, Estimates & Call Transcripts

$1.49
-0.07 (-4.49%)
(As of 06/12/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(May. 8)
-$0.68
Consensus EPS
(May. 8)
-$0.68
Skip Charts & View Estimated and Actual Earnings Data

MRNS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRNS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Marinus Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.76)($0.61)($0.69)
Q2 20243($0.73)($0.52)($0.61)
Q3 20243($0.67)($0.37)($0.53)
Q4 20243($0.63)($0.11)($0.38)
FY 202412($2.79)($1.61)($2.21)
Q1 20251($0.47)($0.47)($0.47)
Q2 20251($0.38)($0.38)($0.38)
Q3 20251($0.31)($0.31)($0.31)
Q4 20251($0.02)($0.02)($0.02)
FY 20254($1.18)($1.18)($1.18)

MRNS Earnings Date and Information

Marinus Pharmaceuticals last released its quarterly earnings data on May 8th, 2024. The biopharmaceutical company reported ($0.68) EPS for the quarter, hitting the consensus estimate of ($0.68). The company earned $7.68 million during the quarter, compared to the consensus estimate of $8.61 million. Marinus Pharmaceuticals has generated ($2.64) earnings per share over the last year (($2.64) diluted earnings per share). Earnings for Marinus Pharmaceuticals are expected to grow in the coming year, from ($1.87) to ($0.90) per share. Marinus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off prior year's report dates.

Marinus Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/8/2024
(Estimated)
------- 
5/8/2024Q1 2024($0.68)($0.68)-($0.68)$8.61 million$7.68 million
3/5/2024Q4 2023($0.64)($0.74)($0.10)($0.74)$7.78 million$7.19 million    
11/7/2023Q3 2023($0.67)($0.61)+$0.06($0.61)$6.54 million$7.34 million
8/10/2023Q2 2023($0.76)($0.61)+$0.15($0.61)$5.14 million$6.08 million    
5/11/2023Q1 2023($0.77)($0.67)+$0.10($0.67)$5.33 million$10.38 million
3/7/2023Q4 2022($0.91)($0.76)+$0.15($0.76)$13.32 million$7.16 million
11/7/2022Q3 2022$0.25($0.35)($0.60)($2.59)$28.56 million$2.34 million
8/11/2022Q2 2022($0.93)($1.06)($0.13)($1.06)$2.25 million$1.79 million
5/12/2022Q1 2022($0.87)($0.52)+$0.35($0.52)$2.19 million$14.19 million
3/21/2022Q4 2021($0.81)($0.77)+$0.04($0.77)$2.64 million$1.52 million    
11/9/2021Q3 2021($0.76)($0.53)+$0.23($0.53)$2.32 million$10.11 million    
8/10/2021Q2 2021($0.68)($0.65)+$0.03($0.65)$2.57 million$1.91 million    
5/17/2021Q1 2021($0.46)($0.74)($0.28)($0.74)$2.61 million$1.81 million  
3/8/2021Q4 2020($0.52)($0.55)($0.03)($0.55)$1.77 million$1.55 million  
11/9/2020Q3 2020($0.60)($0.51)+$0.09($0.51)--  
8/6/2020Q2 2020($0.76)($0.64)+$0.12($0.16)--
5/4/2020Q1 2020($0.64)($1.28)($0.64)($0.32)--  
3/16/2020Q4 2019($0.84)($1.00)($0.16)($0.26)--
11/6/2019Q3($0.9480)($1.04)($0.0920)($0.26)--
8/8/2019Q2 2019($0.9360)($0.96)($0.0240)($0.24)--

Marinus Pharmaceuticals Earnings - Frequently Asked Questions

When is Marinus Pharmaceuticals's earnings date?

Marinus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 8th, 2024 based off last year's report dates. Learn more on MRNS's earnings history.

Did Marinus Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Marinus Pharmaceuticals (NASDAQ:MRNS) reported ($0.68) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.68). Learn more on analysts' earnings estimate vs. MRNS's actual earnings.

How much revenue does Marinus Pharmaceuticals generate each year?

Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded annual revenue of $30.99 million.

How much profit does Marinus Pharmaceuticals generate each year?

Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded net income of -$141.40 million. MRNS has generated -$2.64 earnings per share over the last four quarters.

What is Marinus Pharmaceuticals's EPS forecast for next year?

Marinus Pharmaceuticals's earnings are expected to grow from ($1.87) per share to ($0.90) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MRNS) was last updated on 6/12/2024 by MarketBeat.com Staff

From Our Partners